Net Cash Provided by (Used in) Investing Activities of Shuttle Pharmaceuticals Holdings, Inc. from 31 Mar 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Shuttle Pharmaceuticals Holdings, Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Mar 2023 to 31 Dec 2024.
  • Shuttle Pharmaceuticals Holdings, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $101,295.
  • Shuttle Pharmaceuticals Holdings, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $2,915,765.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

Shuttle Pharmaceuticals Holdings, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,915,765 +$5,745,488 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $2,829,723 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY

Shuttle Pharmaceuticals Holdings, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $101,295 +$3,055,004 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $2,953,709 01 Jan 2023 31 Mar 2023 10-Q/A 04 Sep 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.